We are creating some awesome events for you. Kindly bear with us.

ML-Based Tool Enhances Detection of Glioblastomas

A team of researchers from the Indian Institute of Technology Madras (IIT-Madras) has created a computational tool using machine learning (ML) to enhance the detection of cancerous tumours in the brain and spinal cord. Named ‘GBMDriver’ (GlioBlastoma Multiforme Drivers), this tool is now accessible to the public through an online platform.

Glioblastoma is a highly aggressive tumour that grows rapidly in the brain and spinal cord. Despite research efforts to comprehend this tumour, treatment options remain limited, and the prognosis is typically poor, with a survival rate of less than two years from the initial diagnosis.

Evaluating the functional consequences of protein variants associated with Glioblastoma is crucial for advancing therapeutic options for patients. However, conducting functional validations to identify driver mutations, which are the specific mutations responsible for causing the disease, from the multitude of observed variants would be laborious work.

According to a statement by IIT-Madras, the GBMDriver tool was specifically designed to identify driver mutations, which are responsible for the development of Glioblastoma, and passenger mutations, which are neutral mutations. During the development of the web server, multiple factors were considered, including amino acid properties, di- and tri-peptide motifs, conservation scores, and Position Specific Scoring Matrices (PSSM).

In this study, 9,386 driver mutations and 8,728 passenger mutations in glioblastoma were analysed. Driver mutations in glioblastoma were identified with an accuracy of 81.99%, in a blind set of 1,809 mutants, which is better than existing computational methods. This method is completely dependent on protein sequence, the statement explained.

  1. Michael Gromiha from the Department of Biotechnology at IIT-Madras provided insights into the key findings of the team’s research. He stated that they had successfully identified crucial amino acid features for the identification of cancer-causing mutations and achieved the highest level of accuracy in differentiating between driver and neutral mutations. The team’s aim is for the GBMDriver tool to aid in prioritising driver mutations in glioblastoma and support the identification of potential therapeutic targets. Ultimately, this tool can contribute to the development of effective drug design strategies for the treatment of glioblastoma.

The research findings hold several key applications, including:

  • The methodology and features employed in this research can be adapted and applied to other diseases beyond glioblastoma.
  • The method developed in this research can serve as a significant criterion for predicting disease prognosis. By accurately identifying driver mutations, it can aid in understanding the severity and progression of the disease, contributing to improved patient management and personalised treatment approaches.
  • The research provides a valuable resource to identify mutation-specific drug targets to design therapeutic strategies.

Last year, IIT-Madras researchers developed PIVOT, an artificial intelligence (AI)-based tool that can predict cancer-causing genes. As OpenGov Asia reported, PIVOT predicts cancer-causing genes using a model that utilises information on mutations, expression of genes, and copy number variation in genes and perturbations in the biological network that results from an altered gene expression. The tool applies machine learning to classify genes as tumour suppressor genes, oncogenes, or neutral genes. PIVOT successfully predicted both the existing oncogenes and tumour-suppressor genes like TP53, and PIK3CA, among others, and new cancer-related genes such as PRKCA, SOX9, and PSMD4.

PARTNER

Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.

PARTNER

CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.

PARTNER

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.

SUPPORTING ORGANISATION

SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.

PARTNER

HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 

PARTNER

IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend